Melanoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Melanoma stocks.

Melanoma Stocks Recent News

Date Stock Title
Aug 1 MYGN Myriad Genetics completes sale of EndoPredict Business to Eurobio Scientific
Aug 1 MYGN Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific
Jul 31 MYGN Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer
Jul 30 BMY BMY vs. VRTX: Which Stock Should Value Investors Buy Now?
Jul 30 BMY Pfizer (PFE) Beats on Q2 Earnings & Sales, Raises 2024 View
Jul 30 MYGN Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024
Jul 30 BMY Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?
Jul 29 BMY Barclays cuts Bristol Myers to underweight, cites recent run up
Jul 29 BMY Bristol-Myers stock snaps six days of gains
Jul 29 BMY Bristol-Myers Squibb Earnings Reinforces Our Thesis
Jul 29 BMY Company News for Jul 29, 2024
Jul 29 BMY Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Jul 29 BMY Big Pharma Rallies and Moves Past Obesity
Jul 29 BMY Bristol Myers Squibb reports dip in net income for Q2 2024
Jul 29 BMY Dow Jumps Over 650 Points Following Inflation Data: Fear & Greed Index Moves To 'Neutral' Zone
Jul 28 BMY Bristol Myers Squibb Shows Resilience Amid Patent Expiry Challenges (Rating Upgrade)
Jul 27 BMY Why Wall Street is unfazed by Medicare drug pricing threat
Jul 27 BMY 2 High-Yield Dividend Stocks That Could Shine in 2025
Jul 27 BMY Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point
Jul 27 BMY Q2 2024 Bristol-Myers Squibb Co Earnings Call
Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

Browse All Tags